Showing results (141-150 of 445) with videos related to
Sort By:
Pageof 45
Expert Opinion on Investigational Drugs|July 31, 2019
Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancerAlvaro H Ingles Garces, Lewis Au, Robert Mason, et al.Frontiers in Oncology|September 18, 2015
Sunitinib in Metastatic Renal Cell Carcinoma: A Systematic Review of UK Real World DataMiriam Argyropulo-Palmer, Aaron Jenkins, Davinder Singh Theti, et al.Cells|February 10, 2021
Malignant Melanoma of the Gastrointestinal Tract: Symptoms, Diagnosis, and Current Treatment OptionsDarina Kohoutova, Dominic Worku, Hala Aziz, et al.Future Oncology (London, England)|March 30, 2021
Systematic literature review for the association of biomarkers with efficacy of anti-PD-1 inhibitors in advanced melanomaEmilie Scherrer, Reina Rau, Maria Lorenzi, et al.BMJ Open|April 22, 2021
Promoting physical health among people with enduring mental illness: a qualitative study of healthcare providers' perspectivesClaire Collins, Pearse Finegan, Marie O'Shea, et al.Cell|April 17, 2018
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx RenalSamra Turajlic, Hang Xu, Kevin Litchfield, et al.Cell|April 17, 2018
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx RenalThomas J Mitchell, Samra Turajlic, Andrew Rowan, et al.BJGP Open|August 6, 2021
GPs' perceptions of their relationship with the pharmaceutical industry: a qualitative studyJames Larkin, Ivana Pericin, Maurice Collins, et al.The Australasian Journal of Dermatology|July 3, 2021
Severe progressive scarring pembrolizumab-induced lichen planopilaris in a patient with metastatic melanomaAarthy K Uthayakumar, Emily Rudd, Mariana Noy, et al.The Lancet. Oncology|September 8, 2018
Immune checkpoint inhibitors and cardiovascular toxicityAlexander R Lyon, Nadia Yousaf, Nicolò M L Battisti, et al.Pageof 45